Erasca, Inc 8-K, filed Nov 23, 2021
Erasca, Inc. (ERAS)
About this 8-K
Erasca, Inc filed this 8-K on November 23, 2021, reporting on events of November 19, 2021.
Items reported
- Item 1.01: Entered into a material agreement
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
On November 19, 2021, Erasca, Inc. (the “Company”) entered into a Second Amendment to Lease with BMR-Road to the Cure LP (the “Second Lease Amendment”), which amended that certain Lease, dated as of July 27, 2018, as amended by that certain First Amendment to Lease, dated as of September 16, 2019 (the “Lease”). Pursuant to the Second Lease Amendment, the expiration date of the Lease was changed from May 31, 2024 to April 1, 2022. No additional fees are payable in connection with the execution of the Second Lease Amendment or the expiration of the Lease. The Second Lease Amendment was entered into in connection with the Company’s planned relocation of its corporate headquarters from 10835 Road to the Cure, Suite 140, San Diego, CA 92121 to a new leased premises at 3115 Merryfield Row, Third Floor, San Diego, CA 92121.
A summary of the material terms of the Lease was included in the Company’s Registration Statement on Form S-1 filed on June 25, 2021, which is qualified in its entirety by reference to the full text of the Lease (filed as Exhibit 10.19 to the Company’s Registration Statement on Form S-1 filed on June 25, 2021). The foregoing description of the Second Lease Amendment is a summary and is qualified in its entirety by reference to the full text of the Second Lease Amendment, which the Company expects to file as an exhibit to the Company’s Annual Report on Form 10-K for the 12 months ended December 31, 2021.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
Date: |
November 23, 2021 |
By: |
/s/ Ebun Garner |
|
|
|
Ebun Garner, General Counsel and Secretary |